Patent · US Active

Influenza vaccine

US10736958B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignee

Novavax AB · SE

Inventors

Albertus D. M. E. Osterhaus · Bunnik, NL
Bror Morein · Uppsala, SE
Karin Lövgren Bengtsson · Uppsala, SE

Key dates

Filing date	Jan 29, 2019
Grant date	Aug 11, 2020
Priority date	—
Expiry date	Jan 29, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a composition comprising at least one ISCOM complex and at least one ectodomain from at least one hemagglutinin (HA) domain and at least one ectodomain from at least one neuraminidase (NA) domain from one or more influenza virus, wherein the extodomains represent ectodomains isolated from the influenza virus. The invention also regards a kit. The composition may be used as an immune stimulating medicine, immune modulating pharmaceutical or a vaccine e.g. against influenza for vertebrates, e.g. birds and mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.